fexofenadine has been researched along with Body Weight in 4 studies
fexofenadine: a second generation antihistamine; metabolite of the antihistaminic drug terfenadine; structure in first source; RN refers to HCl
fexofenadine : A piperidine-based anti-histamine compound.
Body Weight: The mass or quantity of heaviness of an individual. It is expressed by units of pounds or kilograms.
| Excerpt | Relevance | Reference |
|---|---|---|
| "In the combined population, the incidence of treatment-emergent adverse events (TEAEs) was comparable between groups (placebo, 48." | 2.73 | Safety and tolerability of fexofenadine hydrochloride, 15 and 30 mg, twice daily in children aged 6 months to 2 years with allergic rhinitis. ( Hampel, FC; Kittner, B; van Bavel, JH, 2007) |
| "Fexofenadine hydrochloride is a non-sedating antihistamine that is used in the treatment of symptoms associated with seasonal allergic rhinitis and chronic idiopathic urticaria." | 1.32 | The utility of mixed-effects covariate analysis in rapid selection of doses in pediatric subjects: a case study with fexofenadine hydrochloride. ( Jensen, BK; Kittner, B; Krishna, R; Krishnaswami, S; Sankoh, AJ, 2004) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mihalic, JT | 1 |
| Fan, P | 1 |
| Chen, X | 2 |
| Fu, Y | 1 |
| Motani, A | 1 |
| Liang, L | 1 |
| Lindstrom, M | 1 |
| Tang, L | 1 |
| Chen, JL | 1 |
| Jaen, J | 1 |
| Dai, K | 1 |
| Li, L | 1 |
| Grime, K | 1 |
| Paine, SW | 1 |
| Krishna, R | 1 |
| Krishnaswami, S | 1 |
| Kittner, B | 2 |
| Sankoh, AJ | 1 |
| Jensen, BK | 1 |
| Hampel, FC | 1 |
| van Bavel, JH | 1 |
1 trial available for fexofenadine and Body Weight
| Article | Year |
|---|---|
Safety and tolerability of fexofenadine hydrochloride, 15 and 30 mg, twice daily in children aged 6 months to 2 years with allergic rhinitis.
Topics: Administration, Oral; Blood Pressure; Body Temperature; Body Weight; Child, Preschool; Electrocardio | 2007 |
3 other studies available for fexofenadine and Body Weight
| Article | Year |
|---|---|
Discovery of a novel melanin concentrating hormone receptor 1 (MCHR1) antagonist with reduced hERG inhibition.
Topics: Animals; Body Weight; Brain; Carbazoles; Cyclohexanecarboxylic Acids; Diet, High-Fat; Dogs; Drug Eva | 2012 |
Species differences in biliary clearance and possible relevance of hepatic uptake and efflux transporters involvement.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily | 2013 |
The utility of mixed-effects covariate analysis in rapid selection of doses in pediatric subjects: a case study with fexofenadine hydrochloride.
Topics: Administration, Oral; Adult; Age Factors; Analysis of Variance; Body Weight; Child; Child, Preschool | 2004 |